Summit Therapeutics Inc.
SMMT
$20.46
$1.668.83%
| Weiss Ratings | SMMT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | SMMT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Good | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | SMMT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 3.16 | |||
| Price History | SMMT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -1.11% | |||
| 30-Day Total Return | -5.28% | |||
| 60-Day Total Return | 12.17% | |||
| 90-Day Total Return | 2.30% | |||
| Year to Date Total Return | 11.50% | |||
| 1-Year Total Return | 431.43% | |||
| 2-Year Total Return | 1,018.03% | |||
| 3-Year Total Return | 759.66% | |||
| 5-Year Total Return | 830.00% | |||
| 52-Week High % Change | -44.53% | |||
| 52-Week Low % Change | 795.24% | |||
| Price | SMMT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $33.89 | |||
| 52-Week Low Price | $2.10 | |||
| 52-Week Low Price (Date) | May 28, 2024 | |||
| 52-Week High Price (Date) | Sep 16, 2024 | |||
| Valuation | SMMT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 13.87B | |||
| Enterprise Value | 13.46B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.32 | |||
| Earnings Per Share Growth | -79.10% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 35.67 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $20.46 | |||
| Enterprise Value/EBITDA (TTM) | -63.84 | |||
| Enterprise Value/EBIT | -63.81 | |||
| Market Cap Category | Large Cap | |||
| Dividends and Shares | SMMT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 737.50M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | SMMT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 305-203-2034 | |||
| Address | 601 Brickell Key Drive Miami, FL 33131 | |||
| Website | www.summittxinc.com | |||
| Country | United States | |||
| Year Founded | 2003 | |||
| Profitability | SMMT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | SMMT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -41.31% | |||
| Return on Equity | -- | |||
| Income Statement | SMMT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -210.90M | |||
| EBIT (TTM) | -210.99M | |||
| Net Income (TTM) | -221.32M | |||
| Net Income Avl. to Common (TTM) | -221.32M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -67.37% | |||
| EPS Diluted (TTM) | -0.32 | |||
| EPS Diluted Growth (Q YOY) | -71.65% | |||
| Balance Sheet | SMMT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 412.35M | |||
| Cash Per Share (Q) | $0.56 | |||
| Total Current Assets (Q) | 423.75M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 388.75M | |||
| Current Ratio (Q) | 10.155 | |||
| Book Value Per Share (Q) | $0.53 | |||
| Total Assets (Q) | 435.56M | |||
| Total Current Liabilities (Q) | 41.73M | |||
| Total Debt (Q) | 7.22M | |||
| Total Liabilities (Q) | 46.81M | |||
| Total Common Equity (Q) | 388.75M | |||
| Cash Flow | SMMT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -205.34M | |||
| Cash from Financing (TTM) | 381.23M | |||
| Net Change in Cash (TTM) | 33.76M | |||
| Levered Free Cash Flow (TTM) | -88.94M | |||
| Cash from Operations (TTM) | -142.11M | |||
